Nice find @Target2017
Gets the mind thinking about the market for China & Asian Countries.
I think this will mean that JW Therapeutics will be watching the IMU-Eureka partnership results closely.
New IP will be developed.
If safe, effective and low cost, and better than what JW Therapeutics has been able to come up with, then this may lead to a potential deal down the track with JW Therapeutics as a logical extension of their existing agreement with Eureka for China & ASEAN countries.
The combinations and permutations of IMU's exciting portfolio is mind boggling.
An exciting day / week / month ahead.
GLTAHs
Ann: Imugene and Eureka Therapeutics onCARlytics Collaboration, page-20
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
